| Period | TIL | SPY | Delta |
|---|---|---|---|
| 3M | -9.5% | +11.4% | -20.8% |
| 6M | -27.5% | +8.2% | -35.6% |
| 1Y | -78.9% | +22.9% | -101.7% |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash and cash equivalents | $6.6M-24.6% | $8.8M-4.2% | $9.2M-79.0% | $43.7M+16.3% | $37.6M |
| Restricted cash | $166K-90.9% | $1.8M+21.9% | $1.5M | $0 | — |
| Marketable securities | $69.5M-33.5% | $104.5M-26.0% | $141.2M-35.0% | $217.2M-47.9% | $416.5M |
| Prepaid expenses and other current assets | $3.0M-67.4% | $9.3M+4.8% | $8.9M+5.2% | $8.5M-14.7% | $9.9M |
| Assets held for sale | $112.1M | $0 | — | — | — |
| Total current assets | $191.4M+53.8% | $124.5M-22.6% | $160.8M-40.3% | $269.4M-41.9% | $464.0M |
| Property, plant and equipment, net | $126K-99.9% | $129.4M-6.7% | $138.7M-29.6% | $196.9M+61.4% | $122.0M |
| Operating lease right-of-use assets | $238K-74.5% | $934K-60.9% | $2.4M-80.8% | $12.5M | $0 |
| Accrued rent receivable | $7.7M+79.6% | $4.3M | — | — | — |
| Other long-term assets | $4.1M-9.4% | $4.5M+602.7% | $639K-81.3% | $3.4M-58.1% | $8.1M |
| Total assets | $203.5M-22.8% | $263.6M-19.1% | $325.6M-32.5% | $482.1M-21.0% | $610.0M |
| Accounts payable | $779K+18.2% | $659K-45.6% | $1.2M-48.6% | $2.4M-57.6% | $5.6M |
| Accrued expenses and other current liabilities | $4.1M-43.8% | $7.2M-22.6% | $9.3M-68.9% | $30.1M-12.7% | $34.4M |
| Total current liabilities | $4.8M-38.7% | $7.9M-25.2% | $10.6M-67.8% | $32.8M-20.7% | $41.4M |
| Contingent consideration | $0-100.0% | $948K-80.5% | $4.9M-38.4% | $7.9M-28.2% | $11.0M |
| Operating lease liabilities, non-current | $0-100.0% | $1.0M-64.7% | $2.9M-44.4% | $5.2M | $0 |
| Loan payable | $84.8M+0.7% | $84.2M+3.4% | $81.4M+12.5% | $72.3M | $0 |
| Other long-term liabilities | $8K-90.4% | $83K+3.8% | $80K-75.9% | $332K+1560.0% | $20K |
| Total liabilities | $89.7M-4.8% | $94.1M-5.7% | $99.8M-15.8% | $118.5M+116.3% | $54.8M |
| Preferred stock, par value $0.000001 per share; 10,000,000 shares authorized; zero shares issued and outstanding as of December 31, 2025, and 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock, par value $0.000001 per share; 300,000,000 shares authorized; 6,781,976 and 6,525,887 shares issued and outstanding as of December 31, 2025, and 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional paid-in capital | $840.9M+2.0% | $824.8M+2.2% | $807.2M+2.3% | $789.0M+4.2% | $757.0M |
| Accumulated other comprehensive loss | -$583K-155.7% | -$228K+34.5% | -$348K+29.4% | -$493K-466.7% | -$87K |
| Accumulated deficit | -$726.5M-10.9% | -$655.1M-12.8% | -$581.0M-36.7% | -$424.9M-110.6% | -$201.7M |
| Total stockholders’ equity | $113.9M-32.8% | $169.4M-25.0% | $225.8M-37.9% | $363.6M-34.5% | $555.2M |
| Total liabilities and stockholders’ equity | $203.5M-22.8% | $263.6M-19.1% | $325.6M-32.5% | $482.1M-21.0% | $610.0M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
No Form 4 transactions on record.
Informational purposes only, not investment advice.